125459 -

For more detailed technical specifications, you can access the full Guideline on Non-Clinical Studies for GTMPs via the official .

: This guideline is a cornerstone for developers of Advanced Therapy Medicinal Products (ATMPs) in the European Union.

The guideline, officially titled , provides a framework for non-clinical studies required before a gene therapy can be used in human clinical trials. Guide to EMA Guideline 125459 125459

: Defining scientific principles for non-clinical studies specifically for gene therapies, which differ significantly from conventional pharmaceuticals. Key Safety Requirements :

: Characterizing potential immune responses to the viral vector or the new protein produced by the therapy. For more detailed technical specifications, you can access

Guideline on the Non-Clinical Studies Required before First ... - EMA

This document outlines the essential safety and efficacy data that developers must generate during the "non-clinical" (animal or lab) phase to justify moving into human subjects. Guide to EMA Guideline 125459 : Defining scientific

: Evaluating whether the viral vector or therapeutic gene could unintentionally be passed on to future generations.